Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 10/20 | 0.57 |
| ▸ | MC5R | P33032 | 10/20 | 0.57 |
| ▸ | MC3R | P41968 | 10/20 | 0.57 |
| ▸ | MC1R | Q01726 | 10/20 | 0.57 |
| ▸ | KDM4A | O75164 | 1/20 | 0.55 |
| ▸ | TACR2 | P21452 | 5/20 | 0.49 |
| ▸ | TSLP | Q969D9 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29924992 | 0.98 | MC4R (0.58) | MC4RMC5RMC3RMC1RKDM4A | |
| SCHEMBL8659758 | 0.87 | KDM4A (0.65) | MC4RMC5RMC3RMC1RKDM4A | |
| SCHEMBL23317973 | 0.85 | OPRM1 (0.58) | MC4RMC5RMC3RMC1RKDM4A | |
| SCHEMBL23318156 | 0.85 | OPRM1 (0.64) | MC4RMC5RMC3RMC1RKDM4A | |
| SCHEMBL29925129 | 0.84 | HDAC8 (0.49) | MC4RMC5RMC3RMC1RKDM4A | |
| SCHEMBL19831554 | 0.84 | OPRM1 (0.61) | MC4RMC5RMC3RMC1RKDM4A | |
| SCHEMBL16488478 | 0.83 | ITGB3 (0.61) | MC4RMC5RMC3RMC1RTSLP | |
| SCHEMBL22215871 | 0.82 | MC4R (0.52) | MC4RMC5RMC3RMC1RKDM4A | |
| SCHEMBL27423920 | 0.82 | MC4R (0.48) | MC4RMC5RMC3RMC1R | |
| SCHEMBL8207851 | 0.82 | MC4R (0.48) | MC4RMC5RMC3RMC1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | AJK BIOPHARMACEUTICAL LLC (US) | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | VIP, HM13, NGLY1 | MC4R 1798/4885MC5R 3698/4885MC3R 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.